You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Serine/threonine kinase 11 (STK11)

Showing 1 - 25 of 5,420
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypertension Trial in Lancaster (Salt loading, Hydrochlorothiazide (HCTZ))

Completed
Has Results
  • Hypertension
  • Salt loading
  • Hydrochlorothiazide (HCTZ)
  • Lancaster, Pennsylvania
    Amish Research Clinics
Mar 23, 2022

NSCLC Trial in Worldwide (Sotorasib)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Birmingham, Alabama
  • +65 more
Nov 29, 2022

NSCLC Trial (Bemcentinib, Pembrolizumab, Pemetrexed)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Jul 19, 2022

NSCLC Trial (Durvalumab, Tremelimumab, Pemetrexed)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Aug 17, 2023

NSCLC Trial in China (JAB 21822)

Recruiting
  • Non-small Cell Lung Cancer
  • JAB 21822
  • Beijing, Beijing, China
  • +20 more
Sep 26, 2022

BRAF V600E, Metastatic Colorectal Cancer Trial in China (Encorafenib, Cetuximab, FOLFIRI)

Recruiting
  • BRAF V600E
  • Metastatic Colorectal Cancer
  • Beijing, Beijing, China
  • +33 more
Dec 20, 2022

Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma Trial in United States

Active, not recruiting
  • Stage III Cutaneous Melanoma AJCC v7
  • +2 more
  • Computed Tomography
  • +3 more
  • Birmingham, Alabama
  • +759 more
Aug 18, 2022

Cancer (With or Without Metastasis) Trial in Houston (TSN084)

Recruiting
  • Cancer (With or Without Metastasis)
  • Houston, Texas
    MD Anderson Cancer Center
Apr 22, 2022

Advanced Solid Tumors Trial in United States (TP-0184)

Completed
  • Advanced Solid Tumors
  • Scottsdale, Arizona
  • +4 more
Apr 4, 2022

Leukemia, Monocytic, Acute, Pediatric AML Trial in China (Cladribine, G-CSF, Cytarabine)

Recruiting
  • Leukemia, Monocytic, Acute
  • Pediatric AML
  • Foshan, Guangdong, China
  • +8 more
Mar 28, 2022

BRAF V600E Unresectable or Metastatic Melanoma, BRAF V600E Metastatic NSCLC, Melanoma Trial in Guangzhou (Encorafenib)

Completed
  • BRAF V600E Unresectable or Metastatic Melanoma
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jun 9, 2022

Low-grade Glioma, Plexiform Neurofibroma, CNS Glioma Trial in Canada (Trametinib)

Active, not recruiting
  • Low-grade Glioma
  • +2 more
  • Calgary, Alberta, Canada
  • +6 more
Oct 25, 2022

Alzheimer, Parkinson Disease Trial in Antalya, Istanbul (Metabolic Cofactor Supplementation, Sorbitol)

Completed
  • Alzheimer Disease
  • Parkinson Disease
  • Metabolic Cofactor Supplementation
  • Sorbitol
  • Antalya, Turkey
  • +1 more
Aug 5, 2022

Advanced Cancer Trial (AB801, Zimberelimab, Docetaxel)

Not yet recruiting
  • Advanced Cancer
  • (no location specified)
Nov 1, 2023

Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression = 1% and an STK11

Recruiting
  • Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation
  • Montpellier, France
  • +7 more
Dec 19, 2022

Lung Cancer Trial in Houston (Cemiplimab, Kevzara (Sarilumab))

Not yet recruiting
  • Lung Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2023

Toxicity, Healthy Trial in Melbourne (GFH312, Placebo)

Recruiting
  • Toxicity
  • Healthy
  • Melbourne, Victoria, Australia
    Nucleus Network Pty Ltd
Jan 18, 2022

Healthy Trial in Toronto (Dietary Intakes)

Completed
  • Healthy
  • Dietary Intakes
  • Toronto, Ontario, Canada
    The Hospital for Sick Children
Oct 24, 2022

NSCLC With STK11/LKB1 Mutation Trial in New York (Daratumumab and Hyaluronidase-fihj, Pre-Intervention Medication,

Not yet recruiting
  • Non-small Cell Lung Cancer With STK11/LKB1 Mutation
  • Daratumumab and Hyaluronidase-fihj
  • +2 more
  • New York, New York
    NYU Langone Health
Mar 29, 2023

Eyelash Growth Trial in Santa Monica (DIME Beauty Eyelash Boost Serum)

Active, not recruiting
  • Eyelash Growth
  • DIME Beauty Eyelash Boost Serum
  • Santa Monica, California
    Citruslabs
Nov 4, 2023

Gastric Type Adenocarcinoma (GAS) With STK11 Mutation Trial in Shanghai (WX390, Toripalimab)

Recruiting
  • Gastric Type Adenocarcinoma (GAS) With STK11 Mutation
  • Shanghai, Shanghai, China
    The Obstetrics & Gynecology Hospital of Fudan University (Shangh
Nov 3, 2023

Hereditary Sensory Neuropathy Type I Trial in London (L-serine, Placebo)

Recruiting
  • Hereditary Sensory Neuropathy Type I
  • London, United Kingdom
    University College London
Oct 31, 2023

Schistosoma Related Bladder Diseases.

Not yet recruiting
  • Schistosoma Haematobium
  • Immunohistochemistry staining,
  • microscopic examination of urine
  • Assiut, Egypt
    Assiut University Hospital
Jul 4, 2023

Real-World Evidence In Patients Treated With Palbociclib

Recruiting
  • Metastatic Breast Cancer
  • Timisoara, Timiș, Romania
  • +5 more
Dec 7, 2022

Advanced Solid Tumor, Advanced or Metastatic NSCLC Trial in Guanzhou, Chengdu (BBP-398)

Recruiting
  • Advanced Solid Tumor
  • Advanced or Metastatic Non-small Cell Lung Cancer
  • Guanzhou, Guangdong, China
  • +1 more
Nov 30, 2022